Examination of Direct-Acting Antiviral treatment for hepatitis C on prognosis and recurrence of hepatocellular carcinoma
Not Applicable
- Conditions
- Hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000038109
- Lead Sponsor
- Matsuyama Red Cross Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who have been refused participation in this study. 2) Child-Pugh before liver resection or RFA is B or C. 3) Cases with distant metastasis before HCC treatment.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method